Fiona Mulcahy

3.3k total citations
48 papers, 2.1k citations indexed

About

Fiona Mulcahy is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Fiona Mulcahy has authored 48 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 20 papers in Virology and 14 papers in Epidemiology. Recurrent topics in Fiona Mulcahy's work include HIV Research and Treatment (20 papers), HIV/AIDS Research and Interventions (17 papers) and HIV/AIDS drug development and treatment (16 papers). Fiona Mulcahy is often cited by papers focused on HIV Research and Treatment (20 papers), HIV/AIDS Research and Interventions (17 papers) and HIV/AIDS drug development and treatment (16 papers). Fiona Mulcahy collaborates with scholars based in Ireland, United Kingdom and United States. Fiona Mulcahy's co-authors include Michael Barry, David Back, Sara Gibbons, John Tjia, S Clarke, Sara E. Gibbons, Concepta Merry, Máirín Ryan, Anne Rompalo and Charmie Godornes and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

Fiona Mulcahy

48 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fiona Mulcahy Ireland 23 1.1k 679 437 428 323 48 2.1k
Kristine B. Patterson United States 26 1.7k 1.5× 1.0k 1.5× 61 0.1× 655 1.5× 144 0.4× 60 2.2k
Philip Cunningham Australia 35 1.6k 1.4× 1.2k 1.8× 329 0.8× 1.5k 3.5× 291 0.9× 113 3.5k
Antonio Ocampo Spain 22 1.0k 0.9× 587 0.9× 152 0.3× 704 1.6× 85 0.3× 86 1.8k
Beverly E. Sha United States 29 828 0.7× 722 1.1× 202 0.5× 1.1k 2.5× 786 2.4× 84 2.4k
Anders Blaxhult Sweden 26 1.6k 1.4× 1.0k 1.5× 101 0.2× 959 2.2× 140 0.4× 73 2.2k
Jason F. Okulicz United States 23 1.3k 1.2× 1.2k 1.7× 88 0.2× 707 1.7× 67 0.2× 137 2.2k
Lillian B. Brown United States 19 876 0.8× 286 0.4× 202 0.5× 484 1.1× 170 0.5× 30 1.4k
B Gazzard United Kingdom 22 647 0.6× 319 0.5× 111 0.3× 477 1.1× 93 0.3× 49 1.4k
Michael P. Dubé United States 33 1.9k 1.7× 1.2k 1.7× 127 0.3× 926 2.2× 82 0.3× 96 3.2k
Siobhan O’Shea United Kingdom 26 1.1k 1.0× 672 1.0× 152 0.3× 794 1.9× 45 0.1× 62 1.7k

Countries citing papers authored by Fiona Mulcahy

Since Specialization
Citations

This map shows the geographic impact of Fiona Mulcahy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona Mulcahy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona Mulcahy more than expected).

Fields of papers citing papers by Fiona Mulcahy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona Mulcahy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona Mulcahy. The network helps show where Fiona Mulcahy may publish in the future.

Co-authorship network of co-authors of Fiona Mulcahy

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona Mulcahy. A scholar is included among the top collaborators of Fiona Mulcahy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona Mulcahy. Fiona Mulcahy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quinn, Laura, et al.. (2020). Virtual HIV pre-exposure prophylaxis outpatient service in the era of COVID-19. International Journal of STD & AIDS. 32(1). 100–103. 12 indexed citations
2.
Davtyan, Hayk, et al.. (2019). Anxiety, depression, and quality of life among HIV positive injection drug users in Ukraine, 2017. The Journal of Infection in Developing Countries. 13(07.1). 111S–117S. 4 indexed citations
3.
Laut, Kamilla Grønborg, Leah Shepherd, Court Pedersen, et al.. (2016). Associations between HIV-RNA-based indicators and virological and clinical outcomes. AIDS. 30(12). 1961–1972. 8 indexed citations
4.
5.
Murphy, Patrick, et al.. (2015). Serostatus Disclosure, Stigma Resistance, and Identity Management Among HIV-Positive Gay Men in Ireland. Qualitative Health Research. 26(11). 1459–1472. 20 indexed citations
6.
Baran, Robert W., Fiona Mulcahy, Ivanka Krznaric, et al.. (2014). Reduced HIV symptoms and improved health‐related quality of life correlate with better access to care for HIV‐1 infected women: the ELLA study. Journal of the International AIDS Society. 17(4S3). 19616–19616. 9 indexed citations
7.
Muldoon, Eavan G., Anne Walsh, Brendan Crowley, & Fiona Mulcahy. (2012). Treponema pallidum Azithromycin Resistance in Dublin, Ireland. Sexually Transmitted Diseases. 39(10). 784–786. 27 indexed citations
8.
Kennedy, Alan, Martina Hennessy, Colm Bergin, et al.. (2011). Ribavirin and Interferon Alter Mmp-9 Abundance In Vitro and in HIV–HCV-Coinfected Patients. Antiviral Therapy. 16(8). 1237–1247. 9 indexed citations
9.
Svärd, Jenny, Paul Spiers, Fiona Mulcahy, & Martina Hennessy. (2010). Nuclear Receptor-Mediated Induction of CYP450 by Antiretrovirals: Functional Consequences of NR1I2 (PXR) Polymorphisms and Differential Prevalence in Whites and Sub-Saharan Africans. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(5). 536–549. 64 indexed citations
10.
Phillips, Andrew, Bruno Ledergerber, Andrzej Horban, et al.. (2004). Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression. AIDS. 18(13). 1795–1804. 25 indexed citations
11.
12.
Lukehart, Sheila A., Charmie Godornes, Barbara J. Molini, et al.. (2004). Macrolide Resistance inTreponema pallidumin the United States and Ireland. New England Journal of Medicine. 351(2). 154–158. 235 indexed citations
13.
Clarke, S, Fiona Mulcahy, John Tjia, et al.. (2001). The pharmacokinetics of methadone in HIV‐positive patients receiving the non‐nucleoside reverse transcriptase inhibitor efavirenz. British Journal of Clinical Pharmacology. 51(3). 213–217. 115 indexed citations
14.
Lewis, Martha J., Fiona Mulcahy, Noreen Sheehy, et al.. (1999). High Rate of Human T Lymphotropic Virus Type IIa Infection in HIV Type 1-Infected Intravenous Drug Abusers in Ireland. AIDS Research and Human Retroviruses. 15(8). 699–705. 28 indexed citations
15.
Merry, Concepta, Michael Barry, Fiona Mulcahy, et al.. (1997). Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients. AIDS. 11(4). F29–F33. 159 indexed citations
16.
Barry, Michael, Sara Gibbons, David Back, & Fiona Mulcahy. (1997). Protease Inhibitors in Patients with HIV Disease. Clinical Pharmacokinetics. 32(3). 194–209. 216 indexed citations
17.
Dunne, Mary, Heather J. Ruskin, & Fiona Mulcahy. (1997). Survival with AIDS in Ireland. AIDS. 11(10). 1281–1290. 25 indexed citations
18.
O’Connor, William, Gillian Murphy, Jane Fogarty, et al.. (1996). Porphyrin abnormalities in acquired immunodeficiency syndrome.. PubMed. 132(12). 1443–7. 34 indexed citations
19.
Bury, Gerard, et al.. (1994). Attitudes towards and Experience of General Practice among HIV-Positive Patients in the Republic of Ireland. International Journal of STD & AIDS. 5(5). 327–331. 5 indexed citations
20.
Mulcahy, Fiona, L D Juby, & G.N. Chandler. (1984). Giant cell arteritis presenting with peripheral neuropathy. Postgraduate Medical Journal. 60(708). 670–671. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristine B. Patterson Breakdown of academic impact, for papers by Philip Cunningham Breakdown of academic impact, for papers by Antonio Ocampo Breakdown of academic impact, for papers by Beverly E. Sha Breakdown of academic impact, for papers by Anders Blaxhult Breakdown of academic impact, for papers by Jason F. Okulicz Breakdown of academic impact, for papers by Lillian B. Brown Breakdown of academic impact, for papers by B Gazzard Breakdown of academic impact, for papers by Michael P. Dubé Breakdown of academic impact, for papers by Siobhan O’Shea
Rankless by CCL
2026